Biotech | August 02, 2021
Bharat Biotech gets WHO prequalification for ROTAVAC 5D
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
Sun Pharma has committed Rs. 100 crores towards these initiatives
Aurobindo has one of the most enduring generics ecosystems among peers
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
India sales grew 23.5% YoY with consolidation of Wockhardt products
The agreement will help ensure wider reach and access to patients in India
Subscribe To Our Newsletter & Stay Updated
